GlaxoSmithKline
This article was originally published in The Tan Sheet
Executive Summary
NicoDerm CQ transdermal patch marketer signs development/commercialization deal with Taisho Pharmaceutical for OTC smoking cessation products in Japan. GSK will supply products, while Taisho will handle sales, distribution. Agreement comes on heels of Japan Ministry of Health's June 20 approval of Pharmacia's Nicorette gum as first OTC smoking cessation aid (1"The Tan Sheet" July 2, In Brief)